Stay updated with breaking news from Swedish Web System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The REDUCE-AMI trial found that long-term beta-blocker therapy does not reduce mortality risk in acute myocardial infarction patients with preserved left ventricular ejection fraction compared to no beta-blocker treatment.
Researchers examined the association between different severity levels of pain a year after myocardial infarction and the risk of all-cause mortality.
Beta-blockers are prescribed as a matter of course to people following a heart attack, but a study found that people who have not experienced cardiac complications after a heart attack gain no improvement in outcomes by taking beta-blockers long-term.
A study has found that low socioeconomic status increases risk for bleeding in patients who have received mechanical aortic valve replacement.
Sweden: A recent study showed no benefit of Bivalirudin versus heparin in patients with STEMI undergoing primary percutaneous coronary intervention (PCI) with radial access and currently recommended...